Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the clinical and radiographic success rate of Miniature pulpotomy with Mineral Trioxide Aggregate (MTA) in primary molars.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Mashhad University of Medical Sciences
NCT05816525 · Deep Caries, Pulpitis Reversible, and more
NCT07452614 · Pulp Disease, Dental, Pulpitis, and more
NCT07297836 · Pulpitis - Irreversible, Pulp Necrosis, and more
NCT07410780 · Symptomatic Irreversible Pulpitis
NCT07340606 · Pulpitis - Irreversible
Mashhad University of Medical Siences
Mashhad, Razavi Khorasan Province
Mashhad University of Medical Siences
Mashhad, Razavi Khorasan Province
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions